IRIS
TEDESCHI, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 621
NA - Nord America 324
EU - Europa 257
SA - Sud America 173
AF - Africa 31
OC - Oceania 1
Totale 1.407
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 294
SG - Singapore 220
IT - Italia 133
BR - Brasile 127
CN - Cina 113
VN - Vietnam 99
BD - Bangladesh 51
HK - Hong Kong 47
DE - Germania 25
FI - Finlandia 20
FR - Francia 20
IN - India 18
AR - Argentina 15
GB - Regno Unito 13
KR - Corea 13
MX - Messico 11
ZA - Sudafrica 11
CA - Canada 10
EC - Ecuador 9
IQ - Iraq 8
CZ - Repubblica Ceca 7
RU - Federazione Russa 7
TR - Turchia 7
UA - Ucraina 7
ID - Indonesia 6
MA - Marocco 6
VE - Venezuela 6
PE - Perù 5
PL - Polonia 5
DZ - Algeria 4
ES - Italia 4
NL - Olanda 4
PH - Filippine 4
PY - Paraguay 4
CL - Cile 3
EG - Egitto 3
HN - Honduras 3
JO - Giordania 3
KZ - Kazakistan 3
MY - Malesia 3
NP - Nepal 3
SA - Arabia Saudita 3
TN - Tunisia 3
UZ - Uzbekistan 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CO - Colombia 2
CR - Costa Rica 2
JP - Giappone 2
PK - Pakistan 2
RO - Romania 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SE - Svezia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
Totale 1.407
Salva come PNG Salva come JPEG
Città #
Singapore 99
Florence 73
San Jose 58
Council Bluffs 55
Hong Kong 47
Hanoi 29
Ashburn 23
Boardman 23
Hefei 23
Beijing 21
Ho Chi Minh City 21
Dallas 19
Lauterbourg 13
Rome 13
Seoul 13
Helsinki 12
Munich 12
Haiphong 11
Los Angeles 10
Noto 10
Sesto Fiorentino 10
Santa Clara 8
São Paulo 8
New York 7
Dhaka 5
Falkenstein 5
Johannesburg 5
Rio de Janeiro 5
Shanghai 5
Turku 5
Warsaw 5
Brooklyn 4
Buffalo 4
Da Nang 4
Frankfurt am Main 4
London 4
Mexico City 4
Montreal 4
Porto Alegre 4
Secaucus 4
Wuhan 4
Amman 3
Baghdad 3
Guangzhou 3
Houston 3
Lappeenranta 3
Miami 3
Nova Iguaçu 3
Phoenix 3
Riyadh 3
Zibo 3
Astana 2
Asunción 2
Belo Horizonte 2
Bologna 2
Brasília 2
Bucharest 2
Buenos Aires 2
Bắc Giang 2
Can Tho 2
Caruaru 2
Catania 2
Charlotte 2
Chennai 2
Cleveland 2
Curitiba 2
Giza 2
Goiânia 2
Guarulhos 2
Itabira 2
Itajaí 2
Kyiv 2
Lima 2
Lviv 2
Manama 2
Monastir 2
Montes Claros 2
Mumbai 2
Naples 2
Natal 2
Ninh Bình 2
Ogden 2
Padua 2
Quito 2
Recife 2
Rende 2
Salvador 2
San Cristóbal 2
San Francisco 2
San José 2
Santiago 2
Seattle 2
Sumaré 2
Surabaya 2
Surat 2
São Bernardo do Campo 2
São Vicente 2
Taichung 2
Tangier 2
Tashkent 2
Totale 821
Salva come PNG Salva come JPEG
Nome #
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 113
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia 107
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study 104
Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib 103
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature 103
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statement 99
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model 94
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement 89
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 86
Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practice 84
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real‐life multicenter Italian cohort 84
Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohort 83
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real‐life experience 78
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study 70
Acalabrutinib in High‐Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real‐Life Experience 66
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real‐World Study 42
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort 24
Totale 1.429
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.243
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202331 0 0 0 0 0 0 14 3 0 2 9 3
2023/2024119 0 2 24 34 11 13 10 5 3 1 1 15
2024/2025255 16 22 0 12 24 21 7 4 18 20 32 79
2025/2026990 113 47 46 83 177 55 122 49 73 101 49 75
2026/202734 34 0 0 0 0 0 0 0 0 0 0 0
Totale 1.429